Showing results (51-60 of 220) with videos related to
Sort By:
Pageof 22
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experienceAnita Shet, Leslie Berry, Hiroshi Mohri, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 22, 2026
Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025Gagandeep Singh, Disha Bhavsar, Lucas M Ferreri, et al.AIDS (London, England)|August 24, 2010
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretroviralsSlim Fourati, Isabelle Malet, Mawuena Binka, et al.Journal of Virology|April 21, 2022
Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal AntibodiesEricka Kirkpatrick Roubidoux, Kaori Sano, Meagan McMahon, et al.Vaccine|January 22, 2020
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assayVeronika Chromikova, Jessica Tan, Sadaf Aslam, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replicationBharat Ramratnam, Ruy Ribeiro, Tian He, et al.Journal of Virology|March 14, 2014
HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cellsRaymond A Alvarez, Rebecca E Hamlin, Anthony Monroe, et al.Plos Pathogens|April 5, 2013
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signalingJuliet Morrison, Maudry Laurent-Rolle, Ana M Maestre, et al.Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
IL-15 regulates susceptibility of CD4+ T cells to HIV infectionLara Manganaro, Patrick Hong, Matthew M Hernandez, et al.Ebiomedicine|January 9, 2026
Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infectionJordan J Clark, Stefan Hatzl, Kirill Vasilev, et al.Pageof 22